Pembrolizumab
- PDF / 168,853 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 111 Downloads / 185 Views
1 S
Hyperthyroidism and pneumonitis: 2 case reports In a single-centre retrospective study of 29 patients conducted between December 2017 and September 2019, two patients [ages and sexes not stated] were described, who developed hyperthyroidism (1 patient) and pneumonitis (1 patient) during treatment with IV infusion of pembrolizumab 100mg every 3 weeks for stage III melanoma [duration of treatments to reaction onsets and outcomes not stated]. Li T, et al. Adjuvant pembrolizumab versus high-dose interferon alpha-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study. Investigational 803517930 New Drugs 38: 1334-1341, 18 Feb 2020. Available from: URL: http://doi.org/10.1007/s10637-020-00913-6
0114-9954/20/1832-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 28 Nov 2020 No. 1832
Data Loading...
